BNTX
BioNTech SE
NASDAQ: BNTX · HEALTHCARE · BIOTECHNOLOGY
$103.45
+1.85% today
Updated 2026-04-30
Market cap
$25.69B
P/E ratio
—
P/S ratio
8.95x
EPS (TTM)
$-5.50
Dividend yield
—
52W range
$80 – $124
Volume
1.2M
BioNTech SE (BNTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-39.60%
Operating margin
-33.40%
ROE
-5.88%
ROA
-3.56%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $61.60M | $-85.65M | 84.87% | -99.48% | -139.05% |
| 2018 | $127.58M | $-48.02M | 89.27% | -42.21% | -37.64% |
| 2019 | $108.60M | $-179.10M | 83.98% | -167.13% | -164.92% |
| 2020 | $482.30M | $15.20M | 87.70% | -17.08% | 3.15% |
| 2021 | $18.98B | $10.29B | 84.66% | 80.54% | 54.24% |
| 2022 | $17.31B | $9.43B | 82.70% | 73.03% | 54.50% |
| 2023 | $3.82B | $930.30M | 84.29% | 18.08% | 24.36% |
| 2024 | $2.75B | $-665.30M | 80.32% | -47.77% | -24.18% |
| 2025 | $2.76B | $-1.09B | 77.64% | -22.63% | -39.59% |